Literature DB >> 22001110

Functions and regulation of the APOBEC family of proteins.

Harold C Smith1, Ryan P Bennett, Ayse Kizilyer, William M McDougall, Kimberly M Prohaska.   

Abstract

APOBEC1 is a cytidine deaminase that edits messenger RNAs and was the first enzyme in the APOBEC family to be functionally characterized. Under appropriate conditions APOBEC1 also deaminates deoxycytidine in single-stranded DNA (ssDNA). The other ten members of the APOBEC family have not been fully characterized however several have deoxycytidine deaminase activity on ssDNAs. Despite the nucleic acid substrate preferences of different APOBEC proteins, a common feature appears to be their intrinsic ability to bind to RNA as well as to ssDNA. RNA binding to APOBEC proteins together with protein-protein interactions, post-translation modifications and subcellular localization serve as biological modulators controlling the DNA mutagenic activity of these potentially genotoxic proteins.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22001110      PMCID: PMC4017262          DOI: 10.1016/j.semcdb.2011.10.004

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  145 in total

1.  Increasing the yield of soluble recombinant protein expressed in E. coli by induction during late log phase.

Authors:  Chad A Galloway; Mark P Sowden; Harold C Smith
Journal:  Biotechniques       Date:  2003-03       Impact factor: 1.993

Review 2.  Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business.

Authors:  Joseph E Wedekind; Geoffrey S C Dance; Mark P Sowden; Harold C Smith
Journal:  Trends Genet       Date:  2003-04       Impact factor: 11.639

3.  RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators.

Authors:  Reuben S Harris; Svend K Petersen-Mahrt; Michael S Neuberger
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

4.  In vitro deamination of cytosine to uracil in single-stranded DNA by apolipoprotein B editing complex catalytic subunit 1 (APOBEC1).

Authors:  Svend K Petersen-Mahrt; Michael S Neuberger
Journal:  J Biol Chem       Date:  2003-04-14       Impact factor: 5.157

5.  Functional characterization of APOBEC-1 complementation factor phosphorylation sites.

Authors:  David M Lehmann; Chad A Galloway; Celeste MacElrevey; Mark P Sowden; Joseph E Wedekind; Harold C Smith
Journal:  Biochim Biophys Acta       Date:  2006-12-08

6.  Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.

Authors:  Martin Hersberger; Susannah Patarroyo-White; Xiaobing Qian; Kay S Arnold; Lucia Rohrer; Maureen E Balestra; Thomas L Innerarity
Journal:  Biochem J       Date:  2003-01-15       Impact factor: 3.857

7.  High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemia.

Authors:  Helen McCarthy; William G Wierda; Lynn L Barron; Candy C Cromwell; Jing Wang; Kevin R Coombes; Roberto Rangel; Kojo S J Elenitoba-Johnson; Michael J Keating; Lynne V Abruzzo
Journal:  Blood       Date:  2003-02-13       Impact factor: 22.113

8.  E-proteins directly regulate expression of activation-induced deaminase in mature B cells.

Authors:  Camil Elie Sayegh; Melanie W Quong; Yasutoshi Agata; Cornelis Murre
Journal:  Nat Immunol       Date:  2003-04-28       Impact factor: 25.606

9.  Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase.

Authors:  Ronda Bransteitter; Phuong Pham; Matthew D Scharff; Myron F Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-21       Impact factor: 11.205

10.  Constitutive expression of AID leads to tumorigenesis.

Authors:  Il-mi Okazaki; Hiroshi Hiai; Naoki Kakazu; Shuichi Yamada; Masamichi Muramatsu; Kazuo Kinoshita; Tasuku Honjo
Journal:  J Exp Med       Date:  2003-05-05       Impact factor: 14.307

View more
  94 in total

1.  APOBEC3 proteins and genomic stability: the high cost of a good defense.

Authors:  Iñigo Narvaiza; Sébastien Landry; Matthew D Weitzman
Journal:  Cell Cycle       Date:  2012-01-01       Impact factor: 4.534

2.  Genetic Architectures of Quantitative Variation in RNA Editing Pathways.

Authors:  Tongjun Gu; Daniel M Gatti; Anuj Srivastava; Elizabeth M Snyder; Narayanan Raghupathy; Petr Simecek; Karen L Svenson; Ivan Dotu; Jeffrey H Chuang; Mark P Keller; Alan D Attie; Robert E Braun; Gary A Churchill
Journal:  Genetics       Date:  2015-11-27       Impact factor: 4.562

3.  Impact of functional germline variants and a deletion polymorphism in APOBEC3A and APOBEC3B on breast cancer risk and survival in a Swedish study population.

Authors:  Stella Göhler; Miguel Inacio Da Silva Filho; Robert Johansson; Kerstin Enquist-Olsson; Roger Henriksson; Kari Hemminki; Per Lenner; Asta Försti
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-31       Impact factor: 4.553

4.  Structural Insights into HIV-1 Vif-APOBEC3F Interaction.

Authors:  Masaaki Nakashima; Hirotaka Ode; Takashi Kawamura; Shingo Kitamura; Yuriko Naganawa; Hiroaki Awazu; Shinya Tsuzuki; Kazuhiro Matsuoka; Michiko Nemoto; Atsuko Hachiya; Wataru Sugiura; Yoshiyuki Yokomaku; Nobuhisa Watanabe; Yasumasa Iwatani
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

5.  Biochemical Regulatory Features of Activation-Induced Cytidine Deaminase Remain Conserved from Lampreys to Humans.

Authors:  Emma M Quinlan; Justin J King; Chris T Amemiya; Ellen Hsu; Mani Larijani
Journal:  Mol Cell Biol       Date:  2017-09-26       Impact factor: 4.272

6.  An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.

Authors:  Steven A Roberts; Michael S Lawrence; Leszek J Klimczak; Sara A Grimm; David Fargo; Petar Stojanov; Adam Kiezun; Gregory V Kryukov; Scott L Carter; Gordon Saksena; Shawn Harris; Ruchir R Shah; Michael A Resnick; Gad Getz; Dmitry A Gordenin
Journal:  Nat Genet       Date:  2013-07-14       Impact factor: 38.330

Review 7.  Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.

Authors:  Belete A Desimmie; Krista A Delviks-Frankenberrry; Ryan C Burdick; DongFei Qi; Taisuke Izumi; Vinay K Pathak
Journal:  J Mol Biol       Date:  2013-11-02       Impact factor: 5.469

Review 8.  Transcriptome complexity in cardiac development and diseases--an expanding universe between genome and phenome.

Authors:  Chen Gao; Yibin Wang
Journal:  Circ J       Date:  2014-04-22       Impact factor: 2.993

Review 9.  Hypermutation in human cancer genomes: footprints and mechanisms.

Authors:  Steven A Roberts; Dmitry A Gordenin
Journal:  Nat Rev Cancer       Date:  2014-12       Impact factor: 60.716

10.  Unusual noncanonical intron editing is important for tRNA splicing in Trypanosoma brucei.

Authors:  Mary Anne T Rubio; Zdeněk Paris; Kirk W Gaston; Ian M C Fleming; Paul Sample; Christopher R Trotta; Juan D Alfonzo
Journal:  Mol Cell       Date:  2013-10-03       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.